Guangdong Transtek Medicl Elctrncs CoLtd (300562) Stock Price & News

(CNY)	Sep 2025	Y/Y change
Revenue	235.76M	-8.53%
Operating expense	58.96M	-18.10%
Net income	23.39M	49.20%
Net profit margin	9.92	63.16%
Earnings per share	—	—
EBITDA	32.45M	16.11%
Effective tax rate	0.50%	—

Balance Sheet

Total assets

Total liabilities

(CNY)	Sep 2025	Y/Y change
Cash and short-term investments	710.35M	2.79%
Total assets	1.42B	-8.69%
Total liabilities	427.31M	-20.61%
Total equity	992.41M	—
Shares outstanding	216.88M	—
Price to book	2.99	—
Return on assets	4.77%	—
Return on capital	6.22%	—

Cash Flow

Net change in cash

(CNY)	Sep 2025	Y/Y change
Net income	23.39M	49.20%
Cash from operations	56.11M	34.08%
Cash from investing	-208.38M	43.05%
Cash from financing	-80.67M	-82.62%
Net change in cash	-235.71M	35.78%
Free cash flow	10.63M	193.73%

About

Transtek Medical, commonly known as Lifesense, fully referred to as Guangdong Transtek Medical Electronics Co., Ltd., is a Chinese wearable device maker that also focuses on the field of mobile health. The company was founded by Weichao Pan in 2002, with its main products being home medical and health electronics, such as scales, smart bracelets and blood pressure monitors. According to IDC, the company shipped one million units of wearables in the second quarter of 2016, ranking fifth in the global wearable devices market, coming in behind Fitbit, Apple and Garmin. Transtek's IPO application was approved by the CSRC in October 2016. On November 16, it landed on the Shenzhen Stock Exchange with the ticker symbol "300562.SZ". Wikipedia

Founded

Jul 18, 2002

Website

lifesense.com

Employees

1,182